This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanglard, D.
Right arrow Articles by Bille, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanglard, D.
Right arrow Articles by Bille, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 1998, p. 241-253, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14alpha -Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Dominique Sanglard,1,* Françoise Ischer,1 Luc Koymans,2 and Jacques Bille1

Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland,1 and Center for Molecular Design, Janssen Research Foundation, Vosselaar, Belgium2

Received 29 September 1997/Returned for modification 29 October 1997/Accepted 17 November 1997

The cytochrome P-450 lanosterol 14alpha -demethylase (CYP51A1) of yeasts is involved in an important step in the biosynthesis of ergosterol. Since CYP51A1 is the target of azole antifungal agents, this enzyme is potentially prone to alterations leading to resistance to these agents. Among them, a decrease in the affinity of CYP51A1 for these agents is possible. We showed in a group of Candida albicans isolates from AIDS patients that multidrug efflux transporters were playing an important role in the resistance of C. albicans to azole antifungal agents, but without excluding the involvement of other factors (D. Sanglard, K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille, Antimicrob. Agents Chemother. 39:2378-2386, 1995). We therefore analyzed in closer detail changes in the affinity of CYP51A1 for azole antifungal agents. A strategy consisting of functional expression in Saccharomyces cerevisiae of the C. albicans CYP51A1 genes of sequential clinical isolates from patients was designed. This selection, which was coupled with a test of susceptibility to the azole derivatives fluconazole, ketoconazole, and itraconazole, enabled the detection of mutations in different cloned CYP51A1 genes, whose products are potentially affected in their affinity for azole derivatives. This selection enabled the detection of five different mutations in the cloned CYP51A1 genes which correlated with the occurrence of azole resistance in clinical C. albicans isolates. These mutations were as follows: replacement of the glycine at position 129 with alanine (G129A), Y132H, S405F, G464S, and R467K. While the S405F mutation was found as a single amino acid substitution in a CYP51A1 gene from an azole-resistant yeast, other mutations were found simultaneously in individual CYP51A1 genes, i.e., R467K with G464S, S405F with Y132H, G129A with G464S, and R467K with G464S and Y132H. Site-directed mutagenesis of a wild-type CYP51A1 gene was performed to estimate the effect of each of these mutations on resistance to azole derivatives. Each single mutation, with the exception of G129A, had a measurable effect on the affinity of the target enzyme for specific azole derivatives. We speculate that these specific mutations could combine with the effect of multidrug efflux transporters in the clinical isolates and contribute to different patterns and stepwise increases in resistance to azole derivatives.

* Corresponding author. Mailing address: Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois, Rue de Bugnon 44, 1011 Lausanne, Switzerland. Phone: 41 21 3144083. Fax: 41 21 3144060. E-mail: dsanglar{at}eliot.unil.ch.

Antimicrobial Agents and Chemotherapy, February 1998, p. 241-253, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Posteraro, B., Martucci, R., La Sorda, M., Fiori, B., Sanglard, D., De Carolis, E., Florio, A. R., Fadda, G., Sanguinetti, M. (2009). Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata. J. Clin. Microbiol. 47: 1927-1930 [Abstract] [Full Text]  
  • Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., Monk, B. C. (2009). Efflux-Mediated Antifungal Drug Resistance. Clin. Microbiol. Rev. 22: 291-321 [Abstract] [Full Text]  
  • Lamping, E., Ranchod, A., Nakamura, K., Tyndall, J. D. A., Niimi, K., Holmes, A. R., Niimi, M., Cannon, R. D. (2009). Abc1p Is a Multidrug Efflux Transporter That Tips the Balance in Favor of Innate Azole Resistance in Candida krusei. Antimicrob. Agents Chemother. 53: 354-369 [Abstract] [Full Text]  
  • Parker, J. E., Merkamm, M., Manning, N. J., Pompon, D., Kelly, S. L., Kelly, D. E. (2008). Differential Azole Antifungal Efficacies Contrasted Using a Saccharomyces cerevisiae Strain Humanized for Sterol 14{alpha}-Demethylase at the Homologous Locus. Antimicrob. Agents Chemother. 52: 3597-3603 [Abstract] [Full Text]  
  • Dunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhauser, J., Rogers, P. D. (2008). A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate. Eukaryot Cell 7: 1180-1190 [Abstract] [Full Text]  
  • Eddine, A. N., von Kries, J. P., Podust, M. V., Warrier, T., Kaufmann, S. H. E., Podust, L. M. (2008). X-ray Structure of 4,4'-Dihydroxybenzophenone Mimicking Sterol Substrate in the Active Site of Sterol 14{alpha}-Demethylase (CYP51). J. Biol. Chem. 283: 15152-15159 [Abstract] [Full Text]  
  • Cowen, L. E., Steinbach, W. J. (2008). Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance. Eukaryot Cell 7: 747-764 [Full Text]  
  • Xu, Y., Chen, L., Li, C. (2008). Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations. J Antimicrob Chemother 61: 798-804 [Abstract] [Full Text]  
  • Luo, C.-X., Schnabel, G. (2008). The Cytochrome P450 Lanosterol 14{alpha}-Demethylase Gene Is a Demethylation Inhibitor Fungicide Resistance Determinant in Monilinia fructicola Field Isolates from Georgia. Appl. Environ. Microbiol. 74: 359-366 [Abstract] [Full Text]  
  • Oliver, B. G., Song, J. L., Choiniere, J. H., White, T. C. (2007). cis-Acting Elements within the Candida albicans ERG11 Promoter Mediate the Azole Response through Transcription Factor Upc2p. Eukaryot Cell 6: 2231-2239 [Abstract] [Full Text]  
  • Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S., Morschhauser, J., Nantel, A., Raymond, M., Rogers, P. D. (2007). Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon. Eukaryot Cell 6: 2122-2138 [Abstract] [Full Text]  
  • Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.-E., d'Enfert, C., Berman, J., Sanglard, D. (2007). Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates. Eukaryot Cell 6: 1889-1904 [Abstract] [Full Text]  
  • Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., Rodriguez-Tudela, J. L. (2007). A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations. Antimicrob. Agents Chemother. 51: 1897-1904 [Abstract] [Full Text]  
  • Andes, D., Forrest, A., Lepak, A., Nett, J., Marchillo, K., Lincoln, L. (2006). Impact of Antimicrobial Dosing Regimen on Evolution of Drug Resistance In Vivo: Fluconazole and Candida albicans.. Antimicrob. Agents Chemother. 50: 2374-2383 [Abstract] [Full Text]  
  • Andes, D., Lepak, A., Nett, J., Lincoln, L., Marchillo, K. (2006). In Vivo Fluconazole Pharmacodynamics and Resistance Development in a Previously Susceptible Candida albicans Population Examined by Microbiologic and Transcriptional Profiling.. Antimicrob. Agents Chemother. 50: 2384-2394 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Sheehan, D. J. (2006). Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing. Clin. Microbiol. Rev. 19: 435-447 [Abstract] [Full Text]  
  • Coste, A., Turner, V., Ischer, F., Morschhauser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., Sanglard, D. (2006). A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans. Genetics 172: 2139-2156 [Abstract] [Full Text]  
  • Quan, H., Cao, Y.-Y., Xu, Z., Zhao, J.-X., Gao, P.-H., Qin, X.-F., Jiang, Y.-Y. (2006). Potent In Vitro Synergism of Fluconazole and Berberine Chloride against Clinical Isolates of Candida albicans Resistant to Fluconazole. Antimicrob. Agents Chemother. 50: 1096-1099 [Abstract] [Full Text]  
  • Vandeputte, P., Larcher, G., Berges, T., Renier, G., Chabasse, D., Bouchara, J.-P. (2005). Mechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis. Antimicrob. Agents Chemother. 49: 4608-4615 [Abstract] [Full Text]  
  • Chau, A. S., Gurnani, M., Hawkinson, R., Laverdiere, M., Cacciapuoti, A., McNicholas, P. M. (2005). Inactivation of Sterol {Delta}5,6-Desaturase Attenuates Virulence in Candida albicans. Antimicrob. Agents Chemother. 49: 3646-3651 [Abstract] [Full Text]  
  • Chapeland-Leclerc, F., Bouchoux, J., Goumar, A., Chastin, C., Villard, J., Noel, T. (2005). Inactivation of the FCY2 Gene Encoding Purine-Cytosine Permease Promotes Cross-Resistance to Flucytosine and Fluconazole in Candida lusitaniae. Antimicrob. Agents Chemother. 49: 3101-3108 [Abstract] [Full Text]  
  • Kudo, M., Ohi, M., Aoyama, Y., Nitahara, Y., Chung, S.-K., Yoshida, Y. (2005). Effects of Y132H and F145L Substitutions on the Activity, Azole Resistance and Spectral Properties of Candida albicans Sterol 14-Demethylase P450 (CYP51): A Live Example Showing the Selection of Altered P450 through Interaction with Environmental Compounds. J Biochem 137: 625-632 [Abstract] [Full Text]  
  • Pinjon, E., Jackson, C. J., Kelly, S. L., Sanglard, D., Moran, G., Coleman, D. C., Sullivan, D. J. (2005). Reduced Azole Susceptibility in Genotype 3 Candida dubliniensis Isolates Associated with Increased CdCDR1 and CdCDR2 Expression. Antimicrob. Agents Chemother. 49: 1312-1318 [Abstract] [Full Text]  
  • Lo, H.-J., Wang, J.-S., Lin, C.-Y., Chen, C.-G., Hsiao, T.-Y., Hsu, C.-T., Su, C.-L., Fann, M.-J., Ching, Y.-T., Yang, Y.-L. (2005). Efg1 Involved in Drug Resistance by Regulating the Expression of ERG3 in Candida albicans. Antimicrob. Agents Chemother. 49: 1213-1215 [Abstract] [Full Text]  
  • Sanguinetti, M., Posteraro, B., Fiori, B., Ranno, S., Torelli, R., Fadda, G. (2005). Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal Resistance. Antimicrob. Agents Chemother. 49: 668-679 [Abstract] [Full Text]  
  • Bellamine, A., Lepesheva, G. I., Waterman, M. R. (2004). Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology. J. Lipid Res. 45: 2000-2007 [Abstract] [Full Text]  
  • Munayyer, H. K., Mann, P. A., Chau, A. S., Yarosh-Tomaine, T., Greene, J. R., Hare, R. S., Heimark, L., Palermo, R. E., Loebenberg, D., McNicholas, P. M. (2004). Posaconazole Is a Potent Inhibitor of Sterol 14{alpha}-Demethylation in Yeasts and Molds. Antimicrob. Agents Chemother. 48: 3690-3696 [Abstract] [Full Text]  
  • Karababa, M., Coste, A. T., Rognon, B., Bille, J., Sanglard, D. (2004). Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters. Antimicrob. Agents Chemother. 48: 3064-3079 [Abstract] [Full Text]  
  • Hooshdaran, M. Z., Barker, K. S., Hilliard, G. M., Kusch, H., Morschhauser, J., Rogers, P. D. (2004). Proteomic Analysis of Azole Resistance in Candida albicans Clinical Isolates. Antimicrob. Agents Chemother. 48: 2733-2735 [Abstract] [Full Text]  
  • Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenca-Estrella, M., Rodriguez-Tudela, J. L. (2004). Substitutions at Methionine 220 in the 14{alpha}-Sterol Demethylase (Cyp51A) of Aspergillus fumigatus Are Responsible for Resistance In Vitro to Azole Antifungal Drugs. Antimicrob. Agents Chemother. 48: 2747-2750 [Abstract] [Full Text]  
  • Chau, A. S., Mendrick, C. A., Sabatelli, F. J., Loebenberg, D., McNicholas, P. M. (2004). Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to Azoles. Antimicrob. Agents Chemother. 48: 2124-2131 [Abstract] [Full Text]  
  • Kaur, R., Castano, I., Cormack, B. P. (2004). Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata: Roles of Calcium Signaling and Mitochondria. Antimicrob. Agents Chemother. 48: 1600-1613 [Abstract] [Full Text]  
  • Song, J. L., Harry, J. B., Eastman, R. T., Oliver, B. G., White, T. C. (2004). The Candida albicans Lanosterol 14-{alpha}-Demethylase (ERG11) Gene Promoter Is Maximally Induced after Prolonged Growth with Antifungal Drugs. Antimicrob. Agents Chemother. 48: 1136-1144 [Abstract] [Full Text]  
  • Lee, M.-K., Williams, L. E., Warnock, D. W., Arthington-Skaggs, B. A. (2004). Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother 53: 217-224 [Abstract] [Full Text]  
  • Li, X., Brown, N., Chau, A. S., Lopez-Ribot, J. L., Ruesga, M. T., Quindos, G., Mendrick, C. A., Hare, R. S., Loebenberg, D., DiDomenico, B., McNicholas, P. M. (2004). Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. J Antimicrob Chemother 53: 74-80 [Abstract] [Full Text]  
  • Leber, R., Fuchsbichler, S., Klobucnikova, V., Schweighofer, N., Pitters, E., Wohlfarter, K., Lederer, M., Landl, K., Ruckenstuhl, C., Hapala, I., Turnowsky, F. (2003). Molecular Mechanism of Terbinafine Resistance in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 47: 3890-3900 [Abstract] [Full Text]  
  • Rodero, L., Mellado, E., Rodriguez, A. C., Salve, A., Guelfand, L., Cahn, P., Cuenca-Estrella, M., Davel, G., Rodriguez-Tudela, J. L. (2003). G484S Amino Acid Substitution in Lanosterol 14-{alpha} Demethylase (ERG11) Is Related to Fluconazole Resistance in a Recurrent Cryptococcus neoformans Clinical Isolate. Antimicrob. Agents Chemother. 47: 3653-3656 [Abstract] [Full Text]  
  • Sanglard, D., Ischer, F., Parkinson, T., Falconer, D., Bille, J. (2003). Candida albicans Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal Agents. Antimicrob. Agents Chemother. 47: 2404-2412 [Abstract] [Full Text]  
  • Pinjon, E., Moran, G. P., Jackson, C. J., Kelly, S. L., Sanglard, D., Coleman, D. C., Sullivan, D. J. (2003). Molecular Mechanisms of Itraconazole Resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 47: 2424-2437 [Abstract] [Full Text]  
  • Nascimento, A. M., Goldman, G. H., Park, S., Marras, S. A. E., Delmas, G., Oza, U., Lolans, K., Dudley, M. N., Mann, P. A., Perlin, D. S. (2003). Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole. Antimicrob. Agents Chemother. 47: 1719-1726 [Abstract] [Full Text]  
  • Barker, K. S., Pearson, M. M., Rogers, P. D. (2003). Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae. J Antimicrob Chemother 51: 1131-1140 [Abstract] [Full Text]  
  • Fukuoka, T., Johnston, D. A., Winslow, C. A., de Groot, M. J., Burt, C., Hitchcock, C. A., Filler, S. G. (2003). Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida krusei. Antimicrob. Agents Chemother. 47: 1213-1219 [Abstract] [Full Text]  
  • Rogers, P. D., Barker, K. S. (2003). Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates. Antimicrob. Agents Chemother. 47: 1220-1227 [Abstract] [Full Text]  
  • Noel, T., Francois, F., Paumard, P., Chastin, C., Brethes, D., Villard, J. (2003). Flucytosine-Fluconazole Cross-Resistance in Purine-Cytosine Permease-Deficient Candida lusitaniae Clinical Isolates: Indirect Evidence of a Fluconazole Uptake Transporter. Antimicrob. Agents Chemother. 47: 1275-1284 [Abstract] [Full Text]  
  • Brun, S., Aubry, C., Lima, O., Filmon, R., Berges, T., Chabasse, D., Bouchara, J.-P. (2003). Relationships between Respiration and Susceptibility to Azole Antifungals in Candida glabrata. Antimicrob. Agents Chemother. 47: 847-853 [Abstract] [Full Text]  
  • Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., Rodriguez-Tudela, J. L. (2003). A Point Mutation in the 14{alpha}-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 47: 1120-1124 [Abstract] [Full Text]  
  • Lupetti, A., Paulusma-Annema, A., Welling, M. M., Dogterom-Ballering, H., Brouwer, C. P. J. M., Senesi, S., van Dissel, J. T., Nibbering, P. H. (2003). Synergistic Activity of the N-Terminal Peptide of Human Lactoferrin and Fluconazole against Candida Species. Antimicrob. Agents Chemother. 47: 262-267 [Abstract] [Full Text]  
  • Zwiers, L.-H., Stergiopoulos, I., Van Nistelrooy, J. G. M., De Waard, M. A. (2002). ABC Transporters and Azole Susceptibility in Laboratory Strains of the Wheat Pathogen Mycosphaerella graminicola. Antimicrob. Agents Chemother. 46: 3900-3906 [Abstract] [Full Text]  
  • Rogers, P. D., Barker, K. S. (2002). Evaluation of Differential Gene Expression in Fluconazole-Susceptible and -Resistant Isolates of Candida albicans by cDNA Microarray Analysis. Antimicrob. Agents Chemother. 46: 3412-3417 [Abstract] [Full Text]  
  • Kobayashi, D., Kondo, K., Uehara, N., Otokozawa, S., Tsuji, N., Yagihashi, A., Watanabe, N. (2002). Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect. Antimicrob. Agents Chemother. 46: 3113-3117 [Abstract] [Full Text]  
  • Perea, S., Lopez-Ribot, J. L., Wickes, B. L., Kirkpatrick, W. R., Dib, O. P., Bachmann, S. P., Keller, S. M., Martinez, M., Patterson, T. F. (2002). Molecular Mechanisms of Fluconazole Resistance in Candida dubliniensis Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis. Antimicrob. Agents Chemother. 46: 1695-1703 [Abstract] [Full Text]  
  • White, T. C., Holleman, S., Dy, F., Mirels, L. F., Stevens, D. A. (2002). Resistance Mechanisms in Clinical Isolates of Candida albicans. Antimicrob. Agents Chemother. 46: 1704-1713 [Abstract] [Full Text]  
  • Martinez, M., Lopez-Ribot, J. L., Kirkpatrick, W. R., Bachmann, S. P., Perea, S., Ruesga, M. T., Patterson, T. F. (2002). Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. J Antimicrob Chemother 49: 515-524 [Abstract] [Full Text]  
  • Nakayama, H., Nakayama, N., Arisawa, M., Aoki, Y. (2001). In Vitro and In Vivo Effects of 14alpha -Demethylase (ERG11) Depletion in Candida glabrata. Antimicrob. Agents Chemother. 45: 3037-3045 [Abstract] [Full Text]  
  • Perea, S., Lopez-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillan, R. A., Martinez, M., Calabrese, D., Sanglard, D., Patterson, T. F. (2001). Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother. 45: 2676-2684 [Abstract] [Full Text]  
  • Osherov, N., Kontoyiannis, D. P., Romans, A., May, G. S. (2001). Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14{{alpha}}-demethylase gene, pdmA. J Antimicrob Chemother 48: 75-81 [Abstract] [Full Text]  
  • Mellado, E., Diaz-Guerra, T. M., Cuenca-Estrella, M., Rodriguez-Tudela, J. L. (2001). Identification of Two Different 14-{alpha} Sterol Demethylase-Related Genes (cyp51A and cyp51B) in Aspergillus fumigatus and Other Aspergillus species. J. Clin. Microbiol. 39: 2431-2438 [Abstract] [Full Text]  
  • Maebashi, K., Niimi, M., Kudoh, M., Fischer, F. J., Makimura, K., Niimi, K., Piper, R. J., Uchida, K., Arisawa, M., Cannon, R. D., Yamaguchi, H. (2001). Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J Antimicrob Chemother 47: 527-536 [Abstract] [Full Text]  
  • Sanglard, D., Ischer, F., Bille, J. (2001). Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata. Antimicrob. Agents Chemother. 45: 1174-1183 [Abstract] [Full Text]  
  • Kakeya, H., Miyazaki, Y., Miyazaki, H., Nyswaner, K., Grimberg, B., Bennett, J. E. (2000). Genetic Analysis of Azole Resistance in the Darlington Strain of Candida albicans. Antimicrob. Agents Chemother. 44: 2985-2990 [Abstract] [Full Text]  
  • Calabrese, D., Bille, J., Sanglard, D. (2000). A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146: 2743-2754 [Abstract] [Full Text]  
  • BOUCHARA, J.-P., ZOUHAIR, R., LE BOUDOUIL, S., RENIER, G., FILMON, R., CHABASSE, D., HALLET, J.-N., DEFONTAINE, A. (2000). In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol 49: 977-984 [Abstract] [Full Text]  
  • Henry, K. W., Nickels, J. T., Edlind, T. D. (2000). Upregulation of ERG Genes in Candida Species by Azoles and Other Sterol Biosynthesis Inhibitors. Antimicrob. Agents Chemother. 44: 2693-2700 [Abstract] [Full Text]  
  • Vargas, K., Messer, S. A., Pfaller, M., Lockhart, S. R., Stapleton, J. T., Hellstein, J., Soll, D. R. (2000). Elevated Phenotypic Switching and Drug Resistance of Candida albicans from Human Immunodeficiency Virus-Positive Individuals prior to First Thrush Episode. J. Clin. Microbiol. 38: 3595-3607 [Abstract] [Full Text]  
  • Arthington-Skaggs, B. A., Warnock, D. W., Morrison, C. J. (2000). Quantitation of Candida albicans Ergosterol Content Improves the Correlation between In Vitro Antifungal Susceptibility Test Results and In Vivo Outcome after Fluconazole Treatment in a Murine Model of Invasive Candidiasis. Antimicrob. Agents Chemother. 44: 2081-2085 [Abstract] [Full Text]  
  • Hamamoto, H., Hasegawa, K., Nakaune, R., Lee, Y. J., Makizumi, Y., Akutsu, K., Hibi, T. (2000). Tandem Repeat of a Transcriptional Enhancer Upstream of the Sterol 14alpha -Demethylase Gene (CYP51) in Penicillium digitatum. Appl. Environ. Microbiol. 66: 3421-3426 [Abstract] [Full Text]  
  • Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S., Scalise, G. (2000). Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750. Antimicrob. Agents Chemother. 44: 1578-1584 [Abstract] [Full Text]  
  • Cowen, L. E., Sanglard, D., Calabrese, D., Sirjusingh, C., Anderson, J. B., Kohn, L. M. (2000). Evolution of Drug Resistance in Experimental Populations of Candida albicans. J. Bacteriol. 182: 1515-1522 [Abstract] [Full Text]  
  • Lamb, D. C., Kelly, D. E., White, T. C., Kelly, S. L. (2000). The R467K Amino Acid Substitution in Candida albicans Sterol 14alpha -Demethylase Causes Drug Resistance through Reduced Affinity. Antimicrob. Agents Chemother. 44: 63-67 [Abstract] [Full Text]  
  • Marichal, P., Gorrens, J., Laurijssens, L., Vermuyten, K., Van Hove, C., Le Jeune, L., Verhasselt, P., Sanglard, D., Borgers, M., Ramaekers, F. C. S., Odds, F., Vanden Bossche, H. (1999). Accumulation of 3-Ketosteroids Induced by Itraconazole in Azole-Resistant Clinical Candida albicans Isolates. Antimicrob. Agents Chemother. 43: 2663-2670 [Abstract] [Full Text]  
  • Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., Bille, J. (1999). The ATP Binding Cassette Transporter Gene CgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents. Antimicrob. Agents Chemother. 43: 2753-2765 [Abstract] [Full Text]  
  • Kontoyiannis, D. P., Sagar, N., Hirschi, K. D. (1999). Overexpression of Erg11p by the Regulatable GAL1 Promoter Confers Fluconazole Resistance in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 43: 2798-2800 [Abstract] [Full Text]  
  • Arthington-Skaggs, B. A., Jradi, H., Desai, T., Morrison, C. J. (1999). Quantitation of Ergosterol Content: Novel Method for Determination of Fluconazole Susceptibility of Candida albicans. J. Clin. Microbiol. 37: 3332-3337 [Abstract] [Full Text]  
  • Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., Vanden Bossche, H. (1999). Contribution of mutations in the cytochrome P450 14{alpha}-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145: 2701-2713 [Abstract] [Full Text]  
  • Favre, B., Didmon, M., Ryder, N. S. (1999). Multiple amino acid substitutions in lanosterol 14{alpha}-demethylase contribute to azole resistance in Candida albicans. Microbiology 145: 2715-2725 [Abstract] [Full Text]  
  • Lopez-Ribot, J. L., McAtee, R. K., Perea, S., Kirkpatrick, W. R., Rinaldi, M. G., Patterson, T. F. (1999). Multiple Resistant Phenotypes of Candida albicans Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother. 43: 1621-1630 [Abstract] [Full Text]  
  • Perepnikhatka, V., Fischer, F. J., Niimi, M., Baker, R. A., Cannon, R. D., Wang, Y.-K., Sherman, F., Rustchenko, E. (1999). Specific Chromosome Alterations in Fluconazole-Resistant Mutants of Candida albicans. J. Bacteriol. 181: 4041-4049 [Abstract] [Full Text]  
  • Asai, K., Tsuchimori, N., Okonogi, K., Perfect, J. R., Gotoh, O., Yoshida, Y. (1999). Formation of Azole-Resistant Candida albicans by Mutation of Sterol 14-Demethylase P450. Antimicrob. Agents Chemother. 43: 1163-1169 [Abstract] [Full Text]  
  • Ha, K. C., White, T. C. (1999). Effects of Azole Antifungal Drugs on the Transition from Yeast Cells to Hyphae in Susceptible and Resistant Isolates of the Pathogenic Yeast Candida albicans. Antimicrob. Agents Chemother. 43: 763-768 [Abstract] [Full Text]  
  • Alarco, A.-M., Raymond, M. (1999). The bZip Transcription Factor Cap1p Is Involved in Multidrug Resistance and Oxidative Stress Response in Candida albicans. J. Bacteriol. 181: 700-708 [Abstract] [Full Text]  
  • Cannon, R.D., Chaffin, W.L. (1999). Oral Colonization By Candida Albicans. CROBM 10: 359-383 [Abstract] [Full Text]  
  • Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., Morschhäuser, J. (1998). Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains. Antimicrob. Agents Chemother. 42: 3065-3072 [Abstract] [Full Text]  
  • Lopez-Ribot, J. L., McAtee, R. K., Lee, L. N., Kirkpatrick, W. R., White, T. C., Sanglard, D., Patterson, T. F. (1998). Distinct Patterns of Gene Expression Associated with Development of Fluconazole Resistance in Serial Candida albicans Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis. Antimicrob. Agents Chemother. 42: 2932-2937 [Abstract] [Full Text]  
  • Orozco, A. S., Higginbotham, L. M., Hitchcock, C. A., Parkinson, T., Falconer, D., Ibrahim, A. S., Ghannoum, M. A., Filler, S. G. (1998). Mechanism of Fluconazole Resistance in Candida krusei. Antimicrob. Agents Chemother. 42: 2645-2649 [Abstract] [Full Text]  
  • Miyazaki, H., Miyazaki, Y., Geber, A., Parkinson, T., Hitchcock, C., Falconer, D. J., Ward, D. J., Marsden, K., Bennett, J. E. (1998). Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1, in Candida glabrata. Antimicrob. Agents Chemother. 42: 1695-1701 [Abstract] [Full Text]  
  • Moran, G. P., Sanglard, D., Donnelly, S. M., Shanley, D. B., Sullivan, D. J., Coleman, D. C. (1998). Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42: 1819-1830 [Abstract] [Full Text]  
  • White, T. C., Marr, K. A., Bowden, R. A. (1998). Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance. Clin. Microbiol. Rev. 11: 382-402 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»